LAMBERTI, GIUSEPPE
LAMBERTI, GIUSEPPE
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Ricercatori a tempo determinato
ARTEMIS: a pilot study comparing AI-based and expert therapeutic decisions in simulated clinical cases of neuroendocrine neoplasms
2026 Lamberti, G.; Panzuto, F.; Massironi, S.; Cives, M.; La Salvia, A.; Spada, F.; Faggiano, A.; Pusceddu, S.; Albertelli, M.; Tafuto, S.; Andrini, E.; Ricci, C.; Campana, D.
Determinants of incidence trends in pancreatic neuroendocrine neoplasms
2026 Lamberti, G.; Andrini, E.; Di Odoardo, A.; Zappi, A.; Ricci, C.; Campana, D.
Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicities
2025 Rossi, S.; Andrini, E.; Rinaldi, R.; Silvestri, T.; Formelli, M. G.; Di Odoardo, A.; Lenzi, B.; Guarino, M.; Campana, D.; Lamberti, G.
Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoids
2025 Galvani, L.; Zappi, A.; Pusceddu, S.; Gelsomino, F.; La Salvia, A.; Oldani, S.; Panzuto, F.; Andrini, E.; Lamberti, G.; Campana, D.
Classic versus innovative strategies for immuno-therapy in pancreatic cancer
2025 Formelli, Maria Giovanna; Palloni, Andrea; Tavolari, Simona; Deiana, Chiara; Andrini, Elisa; Di Marco, Mariacristina; Campana, Davide; Lamberti, Giuseppe; Brandi, Giovanni
Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET).
2025 Di Franco, M; Lamberti, G; Campana, D; Ambrosini, V.
Multifocal paraneoplastic encephalitis associated with anti-GABA-B and anti-Hu antibodies manifesting with status epilepticus and epilepsia partialis continua: Expanding the clinical-radiological spectrum
2025 Viola, V.; Asioli, G. M.; Ferri, L.; Rossi, S.; Andrini, E.; Pierucci, E.; Lamberti, G.; Sambati, L.; Rinaldi, R.; Bisulli, F.; Spinardi, L.; Guarino, M.
Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs
2025 Polici, M.; Caruso, D.; Masci, B.; Marasco, M.; Valanzuolo, D.; Dell'Unto, E.; Zerunian, M.; Campana, D.; De Santis, D.; Lamberti, G.; Iannicelli, E.; Prosperi, D.; Annibale, B.; Laghi, A.; Panzuto, F.; Rinzivillo, M.
Reply to ‘The need for a better classification system for gastric neoplasms’
2025 Lamberti, G.; Campana, D.
Rethinking chromogranin A: unveiling gastrointestinal factors beyond neuroendocrine neoplasms—a narrative review
2025 Romano, E.; Rinzivillo, M.; Lamberti, G.; Marasco, M.; Esposito, G.; Campana, D.; Panzuto, F.
Updates on Pulmonary Neuroendocrine Carcinoids: Progress and Perspectives
2025 Scognamiglio, A.; Zappi, A.; Andrini, E.; Di Odoardo, A.; Campana, D.; La Salvia, A.; Lamberti, G.
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors
2024 Pecci F.; Nakazawa S.; Ricciuti B.; Harada G.; Lee J.K.; Alessi J.V.; Barrichello A.; Vaz V.R.; Lamberti G.; Di Federico A.; Gandhi M.M.; Gazgalis D.; Feng W.W.; Jiang J.; Baldacci S.; Locquet M.-A.; Gottlieb F.H.; Chen M.F.; Lee E.; Haradon D.; Smokovich A.; Voligny E.; Nguyen T.; Goel V.K.; Zimmerman Z.; Atwal S.; Wang X.; Bahcall M.; Heist R.S.; Iqbal S.; Gandhi N.; Elliott A.; Vanderwalde A.M.; Ma P.C.; Halmos B.; Liu S.V.; Che J.; Schrock A.B.; Drilon A.; Janne P.A.; Awad M.M.
Challenges and future perspectives for the use of temozolomide in the treatment of SCLC
2024 Andrini E.; Ricco G.; Zappi A.; Aloi S.; Giordano M.; Altimari A.; Gruppioni E.; Maloberti T.; de Biase D.; Campana D.; Lamberti G.
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database
2024 Panzuto, F.; Partelli, S.; Campana, D.; De Braud, F.; Spada, F.; Cives, M.; Tafuto, S.; Bertuzzi, A.; Gelsomino, F.; Bergamo, F.; Marcucci, S.; Mastrangelo, L.; Massironi, S.; Appetecchia, M.; Filice, A.; Badalamenti, G.; Bartolomei, M.; Amoroso, V.; Landoni, L.; Rodriquenz, M. G.; Valente, M.; Colao, A.; Isidori, A.; Fanciulli, G.; Bollina, R.; Ciola, M.; Butturini, G.; Marconcini, R.; Arvat, E.; Cinieri, S.; Berardi, R.; Baldari, S.; Riccardi, F.; Spoto, C.; Giuffrida, D.; Gattuso, D.; Ferone, D.; Rinzivillo, M.; Bertani, E.; Versari, A.; Zerbi, A.; Lamberti, G.; Lauricella, E.; Pusceddu, S.; Fazio, N.; Dell'Unto, E.; Marini, M.; Falconi, M.
Gastric neuroendocrine neoplasms
2024 Lamberti, Giuseppe; Panzuto, Francesco; Pavel, Marianne; O'Toole, Dermot; Ambrosini, Valentina; Falconi, Massimo; Garcia-Carbonero, Rocio; Riechelmann, Rachel P.; Rindi, Guido; Campana, Davide
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer
2024 Ricciuti B.; Lamberti G.; Puchala S.R.; Mahadevan N.R.; Lin J.-R.; Alessi J.V.; Chowdhury A.; Li Y.Y.; Wang X.; Spurr L.; Pecci F.; Di Federico A.; Venkatraman D.; Barrichello A.P.; Gandhi M.; Vaz V.R.; Pangilinan A.J.; Haradon D.; Lee E.; Gupta H.; Pfaff K.L.; Welsh E.L.; Nishino M.; Cherniack A.D.; Johnson B.E.; Weirather J.L.; Dryg I.D.; Rodig S.J.; Sholl L.M.; Sorger P.; Santagata S.; Umeton R.; Awad M.M.
Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer
2024 Di Federico, A.; Alden, S. L.; Smithy, J. W.; Ricciuti, B.; Alessi, J. V.; Wang, X.; Pecci, F.; Lamberti, G.; Gandhi, M. M.; Vaz, V. R.; Spurr, L. F.; Sholl, L. M.; Pfaff, K. L.; Rodig, S. J.; Li, Y. Y.; Cherniack, A. D.; Nishino, M.; Johnson, B. E.; Awad, M. M.
Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients
2024 Bonazzi, Norma; Fortunati, Emilia; Zanoni, Lucia; Argalia, Giulia; Calabrò, Diletta; Tabacchi, Elena; Allegri, Vincenzo; Campana, Davide; Andrini, Elisa; Lamberti, Giuseppe; Di Franco, Martina; Casadei, Riccardo; Ricci, Claudio; Mosconi, Cristina; Fanti, Stefano; Ambrosini, Valentina
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study
2024 Fletcher K.; Cortellini A.; Ganta T.; Kankaria R.; Song H.; Ye F.; Irlmeier R.; Debnath N.; Saeed A.; Radford M.; Alahmadi A.; Diamond A.; Hoimes C.; Presley C.J.; Owen D.H.; Abou Alaiwi S.; Nassar A.H.; Lamberti G.; Perrone F.; Buti S.; Giusti R.; Filetti M.; Vanella V.; Mallardo D.; Sussman T.A.; Galetta D.; Kalofonou F.; Daniels E.; Ascierto P.A.; Pinato D.J.; Nebhan C.; Berg S.; Choueiri T.K.; Marron T.U.; Wang Y.; Naqash A.R.; Johnson D.B.
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort
2024 Panzuto F.; Andrini E.; Lamberti G.; Pusceddu S.; Rinzivillo M.; Gelsomino F.; Raimondi A.; Bongiovanni A.; Davi M.V.; Cives M.; Brizzi M.P.; Persano I.; Zatelli M.C.; Puliafito I.; Tafuto S.; Campana D.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| ARTEMIS: a pilot study comparing AI-based and expert therapeutic decisions in simulated clinical cases of neuroendocrine neoplasms | Lamberti, G.; Panzuto, F.; Massironi, S.; Cives, M.; La Salvia, A.; Spada, F.; Faggiano, A.; Pusc...eddu, S.; Albertelli, M.; Tafuto, S.; Andrini, E.; Ricci, C.; Campana, D. | 2026-01-01 | NPJ DIGITAL MEDICINE | - | 1.01 Articolo in rivista | s41746-025-02274-x.pdf; 41746_2025_2274_MOESM1_ESM (1).pdf |
| Determinants of incidence trends in pancreatic neuroendocrine neoplasms | Lamberti, G.; Andrini, E.; Di Odoardo, A.; Zappi, A.; Ricci, C.; Campana, D. | 2026-01-01 | JOURNAL OF NEUROENDOCRINOLOGY | - | 1.01 Articolo in rivista | JNE-38-e70136.pdf; jne70136-sup-0001-supinfo.pdf |
| Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicities | Rossi, S.; Andrini, E.; Rinaldi, R.; Silvestri, T.; Formelli, M. G.; Di Odoardo, A.; Lenzi, B.; G...uarino, M.; Campana, D.; Lamberti, G. | 2025-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | fimmu-16-1681765.pdf; file supplementari (4).zip |
| Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoids | Galvani, L.; Zappi, A.; Pusceddu, S.; Gelsomino, F.; La Salvia, A.; Oldani, S.; Panzuto, F.; Andr...ini, E.; Lamberti, G.; Campana, D. | 2025-01-01 | ENDOCRINE | - | 1.01 Articolo in rivista | unpaywall-bitstream--1522352687.pdf |
| Classic versus innovative strategies for immuno-therapy in pancreatic cancer | Formelli, Maria Giovanna; Palloni, Andrea; Tavolari, Simona; Deiana, Chiara; Andrini, Elisa; Di M...arco, Mariacristina; Campana, Davide; Lamberti, Giuseppe; Brandi, Giovanni | 2025-01-01 | ADVANCED DRUG DELIVERY REVIEWS | - | 1.01 Articolo in rivista | 2025_Classic Versus innovative strategies for immuno-therapy in pancreatic cancer.pdf |
| Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET). | Di Franco, M; Lamberti, G; Campana, D; Ambrosini, V. | 2025-01-01 | SEMINARS IN NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | 1-s2.0-S0001299825000492-main.pdf |
| Multifocal paraneoplastic encephalitis associated with anti-GABA-B and anti-Hu antibodies manifesting with status epilepticus and epilepsia partialis continua: Expanding the clinical-radiological spectrum | Viola, V.; Asioli, G. M.; Ferri, L.; Rossi, S.; Andrini, E.; Pierucci, E.; Lamberti, G.; Sambati,... L.; Rinaldi, R.; Bisulli, F.; Spinardi, L.; Guarino, M. | 2025-01-01 | JOURNAL OF NEUROIMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs | Polici, M.; Caruso, D.; Masci, B.; Marasco, M.; Valanzuolo, D.; Dell'Unto, E.; Zerunian, M.; Camp...ana, D.; De Santis, D.; Lamberti, G.; Iannicelli, E.; Prosperi, D.; Annibale, B.; Laghi, A.; Panzuto, F.; Rinzivillo, M. | 2025-01-01 | JOURNAL OF NEUROENDOCRINOLOGY | - | 1.01 Articolo in rivista | JNE-37-e13472.pdf |
| Reply to ‘The need for a better classification system for gastric neoplasms’ | Lamberti, G.; Campana, D. | 2025-01-01 | NATURE REVIEWS. DISEASE PRIMERS | - | 1.04 Replica / breve intervento (e simili) | - |
| Rethinking chromogranin A: unveiling gastrointestinal factors beyond neuroendocrine neoplasms—a narrative review | Romano, E.; Rinzivillo, M.; Lamberti, G.; Marasco, M.; Esposito, G.; Campana, D.; Panzuto, F. | 2025-01-01 | TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY | - | 1.03 Recensione in rivista | - |
| Updates on Pulmonary Neuroendocrine Carcinoids: Progress and Perspectives | Scognamiglio, A.; Zappi, A.; Andrini, E.; Di Odoardo, A.; Campana, D.; La Salvia, A.; Lamberti, G. | 2025-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.03 Recensione in rivista | - |
| Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors | Pecci F.; Nakazawa S.; Ricciuti B.; Harada G.; Lee J.K.; Alessi J.V.; Barrichello A.; Vaz V.R.; L...amberti G.; Di Federico A.; Gandhi M.M.; Gazgalis D.; Feng W.W.; Jiang J.; Baldacci S.; Locquet M.-A.; Gottlieb F.H.; Chen M.F.; Lee E.; Haradon D.; Smokovich A.; Voligny E.; Nguyen T.; Goel V.K.; Zimmerman Z.; Atwal S.; Wang X.; Bahcall M.; Heist R.S.; Iqbal S.; Gandhi N.; Elliott A.; Vanderwalde A.M.; Ma P.C.; Halmos B.; Liu S.V.; Che J.; Schrock A.B.; Drilon A.; Janne P.A.; Awad M.M. | 2024-01-01 | CANCER DISCOVERY | - | 1.01 Articolo in rivista | cd-23-1217.pdf; 7384706.zip |
| Challenges and future perspectives for the use of temozolomide in the treatment of SCLC | Andrini E.; Ricco G.; Zappi A.; Aloi S.; Giordano M.; Altimari A.; Gruppioni E.; Maloberti T.; de... Biase D.; Campana D.; Lamberti G. | 2024-01-01 | CANCER TREATMENT REVIEWS | - | 1.01 Articolo in rivista | - |
| Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database | Panzuto, F.; Partelli, S.; Campana, D.; De Braud, F.; Spada, F.; Cives, M.; Tafuto, S.; Bertuzzi,... A.; Gelsomino, F.; Bergamo, F.; Marcucci, S.; Mastrangelo, L.; Massironi, S.; Appetecchia, M.; Filice, A.; Badalamenti, G.; Bartolomei, M.; Amoroso, V.; Landoni, L.; Rodriquenz, M. G.; Valente, M.; Colao, A.; Isidori, A.; Fanciulli, G.; Bollina, R.; Ciola, M.; Butturini, G.; Marconcini, R.; Arvat, E.; Cinieri, S.; Berardi, R.; Baldari, S.; Riccardi, F.; Spoto, C.; Giuffrida, D.; Gattuso, D.; Ferone, D.; Rinzivillo, M.; Bertani, E.; Versari, A.; Zerbi, A.; Lamberti, G.; Lauricella, E.; Pusceddu, S.; Fazio, N.; Dell'Unto, E.; Marini, M.; Falconi, M. | 2024-01-01 | ENDOCRINE | - | 1.01 Articolo in rivista | Endocrine_Panzuto_Itanet.pdf; 12020_2023_3649_MOESM1_ESM.docx |
| Gastric neuroendocrine neoplasms | Lamberti, Giuseppe; Panzuto, Francesco; Pavel, Marianne; O'Toole, Dermot; Ambrosini, Valentina; F...alconi, Massimo; Garcia-Carbonero, Rocio; Riechelmann, Rachel P.; Rindi, Guido; Campana, Davide | 2024-01-01 | NATURE REVIEWS. DISEASE PRIMERS | - | 1.01 Articolo in rivista | - |
| Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer | Ricciuti B.; Lamberti G.; Puchala S.R.; Mahadevan N.R.; Lin J.-R.; Alessi J.V.; Chowdhury A.; Li ...Y.Y.; Wang X.; Spurr L.; Pecci F.; Di Federico A.; Venkatraman D.; Barrichello A.P.; Gandhi M.; Vaz V.R.; Pangilinan A.J.; Haradon D.; Lee E.; Gupta H.; Pfaff K.L.; Welsh E.L.; Nishino M.; Cherniack A.D.; Johnson B.E.; Weirather J.L.; Dryg I.D.; Rodig S.J.; Sholl L.M.; Sorger P.; Santagata S.; Umeton R.; Awad M.M. | 2024-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | jco-42-1311.pdf |
| Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer | Di Federico, A.; Alden, S. L.; Smithy, J. W.; Ricciuti, B.; Alessi, J. V.; Wang, X.; Pecci, F.; L...amberti, G.; Gandhi, M. M.; Vaz, V. R.; Spurr, L. F.; Sholl, L. M.; Pfaff, K. L.; Rodig, S. J.; Li, Y. Y.; Cherniack, A. D.; Nishino, M.; Johnson, B. E.; Awad, M. M. | 2024-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients | Bonazzi, Norma; Fortunati, Emilia; Zanoni, Lucia; Argalia, Giulia; Calabrò, Diletta; Tabacchi, El...ena; Allegri, Vincenzo; Campana, Davide; Andrini, Elisa; Lamberti, Giuseppe; Di Franco, Martina; Casadei, Riccardo; Ricci, Claudio; Mosconi, Cristina; Fanti, Stefano; Ambrosini, Valentina | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-16-00701.pdf |
| Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study | Fletcher K.; Cortellini A.; Ganta T.; Kankaria R.; Song H.; Ye F.; Irlmeier R.; Debnath N.; Saeed... A.; Radford M.; Alahmadi A.; Diamond A.; Hoimes C.; Presley C.J.; Owen D.H.; Abou Alaiwi S.; Nassar A.H.; Lamberti G.; Perrone F.; Buti S.; Giusti R.; Filetti M.; Vanella V.; Mallardo D.; Sussman T.A.; Galetta D.; Kalofonou F.; Daniels E.; Ascierto P.A.; Pinato D.J.; Nebhan C.; Berg S.; Choueiri T.K.; Marron T.U.; Wang Y.; Naqash A.R.; Johnson D.B. | 2024-01-01 | CANCER LETTERS | - | 1.01 Articolo in rivista | Fletcher_2024.pdf |
| Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort | Panzuto F.; Andrini E.; Lamberti G.; Pusceddu S.; Rinzivillo M.; Gelsomino F.; Raimondi A.; Bongi...ovanni A.; Davi M.V.; Cives M.; Brizzi M.P.; Persano I.; Zatelli M.C.; Puliafito I.; Tafuto S.; Campana D. | 2024-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-13-02074.pdf |